GALECTIN THERAPEUTICS INC. Conversion of Stock, Shares Issued
GALECTIN THERAPEUTICS INC. (GALT) reported Conversion of Stock, Shares Issued of 81.59 thousand shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2014-03-21
- GALECTIN THERAPEUTICS INC. conversion of stock, shares issued for fiscal 2013 was 81.59K shares, a 57.42% increase from fiscal 2012.
- GALECTIN THERAPEUTICS INC. conversion of stock, shares issued for fiscal 2012 was 51.83K shares, a 19.36% decline from fiscal 2011.
- GALECTIN THERAPEUTICS INC. conversion of stock, shares issued for fiscal 2011 was 64.27K shares.
| Period end | Conversion of Stock, Shares Issued 12 month |
|---|---|
| 2013-12-31 | 81.59K shares 10-K · filed 2014-03-21 |
| 2012-12-31 | 51.83K shares 10-K · filed 2014-03-21 |
| 2011-12-31 | 64.27K shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |